A study involving over 18,000 patients with the condition found that by 36 months, 19% progressed to neovascular AMD, which doubled the risk of exudative conversion in the fellow eye.
Post hoc analysis of AREDS data clarifies the regimen’s effect in reducing lesion growth toward the fovea, a finding that could support vision preservation among patients with late-stage disease.
Understanding these features may help disease diagnosis in Asian populations. Patients with the former subtype were significantly younger, predominantly male and had a slower progression rate.
Progression is positively associated with non-exudative subretinal fluid and hyperreflective material as well as iRORA. It’s negatively associated with retinal pseudocysts and subfoveal choroid thickness.
After 24 months of treatment with oral minocycline, participants showed no significant decrease in lesion enlargement rate. Mild and moderate AEs were also common.